Medical Condition News

RSS

Special issue explores military applications of acupuncture

The current issue of Medical Acupuncture, a peer-reviewed journal published by Mary Ann Liebert, Inc., explores how the U.S. military is incorporating medical acupuncture to assist in the medical care of military personnel serving in the war zones and the efforts underway to explore military applications of acupuncture.

5 Jan 2012

Married patients benefit from herniated spinal disc surgery

Some patient subgroups see greater improvement after surgery for herniated spinal discs relative to nonoperative outcomes—notably including married patients whose symptoms are getting worse, reports a study in the January 15, 2012, issue of Spine.

5 Jan 2012

Researchers urged to differentiate between two bladder cancer subtypes in their studies

Researchers are being urged to differentiate between two types of bladder cancer when they carry out studies, after a detailed trends analysis revealed significant differences between the main subtypes of the disease.

5 Jan 2012

Article focuses on new optical tools that use laser beams to peer painlessly below the skin

A hand-held scanner, reminiscent of the fictional Star Trek medical Tricorder, images blood vessels through the skin and projects a map onto the skin showing nurses exactly where to insert a needle.

5 Jan 2012

Doctors may need to adjust seizure drug doses for people with HIV/AIDS: New AAN guideline

A new guideline issued by the American Academy of Neurology recommends doctors use caution when choosing seizure drugs for people with HIV/AIDS to avoid potential drug interactions.

5 Jan 2012

Probiodrug secures EUR 15M for clinical development of PQ912

Probiodrug AG today announced it has secured EUR 15 million additional financing for the ongoing development of its glutaminyl cyclase (QC) inhibitor program. The lead compound, PQ912, its first QC inhibitor, is in clinical development for the treatment of Alzheimer's disease.

5 Jan 2012

Working Group recommends use of biomarkers in AD clinical trials

A group of thought leaders in Alzheimer's disease says the science is solid and the time has come for more widespread use of biomarkers in Alzheimer disease (AD) clinical trials, to speed the identification of effective disease-modifying treatments for this incurable disorder.

5 Jan 2012

Re-introduction of rotavirus vaccine does not increase intussusception rates in the U.S.

The rotovirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these potentially fatal side effects, according to a new study by child health experts at C.S. Mott Children's Hospital.

5 Jan 2012

BMI method can determine expected body weight for adolescents with eating disorders

An exact determination of expected body weight for adolescents based on age, height and gender is critical for diagnosis and management of eating disorders such as anorexia nervosa and bulimia. However, there are no clear guidelines regarding the appropriate method for calculating this weight in children with such disorders.

5 Jan 2012

ACS report shows decline in overall cancer death rates

The American Cancer Society's annual cancer statistics report shows that between 2004 and 2008, overall cancer incidence rates declined by 0.6% per year in men and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.6% per year in women.

5 Jan 2012

Itamar, Roche to further develop EndoPAT technology for pre-clinical trials

Itamar-Medical, the world's leader of non-invasive devices for diagnosis of cardiovascular health, announced achievement of the next milestone of the international pharmaceutical company, Roche, to further develop the EndoPAT technology for pre-clinical trials.

5 Jan 2012

Hypothermia rarely used in the U.S. hospitals to reduce heart attack cases

Therapeutic hypothermia has been proven to reduce mortality and improve neurologic outcomes after a heart attack, yet it was rarely used in a sample of more than 26,000 patients, according to a study published in Therapeutic Hypothermia and Temperature Management, a peer-reviewed journal published by Mary Ann Liebert, Inc.

5 Jan 2012

JHTR, COMBI introduce 'Tools for Clinical Use'

Starting this month, The Journal of Head Trauma Rehabilitation (JHTR)—in partnership with The Center For Outcome Measurement in Brain Injury (COMBI)—introduces a new feature designed to support effective and informed use of standardized assessments for evaluation of brain injury.

5 Jan 2012

New brochure makes planning and monitoring post-cancer exercise easy

Not only is overall quality of life higher in cancer survivors who exercise, but the rate of cancer recurrence is lower. Unfortunately, though most doctors recommend exercise, many patients fail to follow through.

5 Jan 2012

Celldex begins rindopepimut and Avastin Phase 2 combination trial in EGFRvIII-positive GB

Celldex Therapeutics, Inc. today announced that patient screening has initiated in a Phase 2 trial of rindopepimut in combination with Avastin in patients with recurrent epidermal growth factor variant III (EGFRvIII)-positive glioblastoma, called the "ReACT Study."

5 Jan 2012

UCSD scientist honored for Down syndrome research

William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine and Chairman of the U.S. Scientific Advisory Committee of the J-r-me Lejeune Foundation, was recognized by U.S. Congressman Pete Sessions from the floor of the House of Representatives in December. Sessions said of Mobley - who received the International Sisley-J-r-me Lejeune Prize in a ceremony at the Museum of Medical History in Paris on December 8.

5 Jan 2012

Bionomics, Ironwood partner to develop and commercialize novel anti-anxiety compound

Ironwood Pharmaceuticals, Inc. and Bionomics Limited today announced that they entered into a collaboration, research, and licensing agreement that will enable Ironwood to develop and commercialize Bionomics' investigational anti-anxiety compound BNC210 and other related compounds.

5 Jan 2012

Medical Condition News

Special issue explores military applications of acupuncture

Married patients benefit from herniated spinal disc surgery

Researchers urged to differentiate between two bladder cancer subtypes in their studies

Article focuses on new optical tools that use laser beams to peer painlessly below the skin

Doctors may need to adjust seizure drug doses for people with HIV/AIDS: New AAN guideline

Probiodrug secures EUR 15M for clinical development of PQ912

Working Group recommends use of biomarkers in AD clinical trials

Re-introduction of rotavirus vaccine does not increase intussusception rates in the U.S.

BMI method can determine expected body weight for adolescents with eating disorders

ACS report shows decline in overall cancer death rates

Itamar, Roche to further develop EndoPAT technology for pre-clinical trials

Hypothermia rarely used in the U.S. hospitals to reduce heart attack cases

JHTR, COMBI introduce 'Tools for Clinical Use'

New brochure makes planning and monitoring post-cancer exercise easy

Celldex begins rindopepimut and Avastin Phase 2 combination trial in EGFRvIII-positive GB

UCSD scientist honored for Down syndrome research

Bionomics, Ironwood partner to develop and commercialize novel anti-anxiety compound

RGS9-2 gene plays a role in regulating body weight

Antiestrogen supplements may reduce risk of melanoma in women with breast cancer

Positive results from Alkermes ALKS 5461 phase 1/2 study on MDD

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News